The Timken Company logo TKR - The Timken Company

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 15
HOLD 9
SELL 0
STRONG
SELL
0
| PRICE TARGET: $142.86 DETAILS
HIGH: $160.00
LOW: $130.00
MEDIAN: $140.00
CONSENSUS: $142.86
UPSIDE: 22.54%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Strong
Trading 89.1% above fair value
Current Price $116.58
Bear Case $49.32 57.7% downside ($49.32 - $116.58) / $116.58 = -57.7% $4.11 × 12x P/E
Fair Value $61.65 47.1% downside ($61.65 - $116.58) / $116.58 = -47.1% $4.11 × 15x P/E
Bull Case $73.98 36.5% downside ($73.98 - $116.58) / $116.58 = -36.5% $4.11 × 18x P/E

Adjust Assumptions

15.0x
4.11$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 28.4x

Plain-Language Summary

Applying a 15x P/E to adjusted EPS of $4.11, the base-case value is $61.65 per share. DDM cross-check: $29.77.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (24 analysts) $142.86
Analyst Range $130.00 – $160.00
Divergence from AlphaVal 57%

Warnings

Dividend-based valuation: $29.77 (below our primary estimate by 52%). Large gaps may signal the dividend doesn't reflect full earning power.
Wall Street's average price target is $142.86 (from 24 analysts). Our estimate is 57% below the consensus -- consider that gap carefully.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples